Meningococcal Polysaccharide Vaccine

Meningococcal Polysaccharide Vaccine is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W-135, and Y.

1904 generics available

D-chiro-inositol + Myo-inositol

This preparation tablet is indicated for the treatment and prevention of-

• Polycystic ovary syndrome (PCOS) associated symptoms such as menstrual irregularity, anovulation, hirsutism, acanthosis nigricans, acne, obesity and PCOS associated infertility
• Gestational diabetes mellitus
• Ovarian hyperstimulation syndrome
• Infertility
• Miscarriage

1904 generics available

Dabigatran Etexilate Mesylate

Dabigatran Etexilate Mesylate is a direct thrombin inhibitor indicated:

• To reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
• For the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for 5-10 days.
• To reduce the risk of recurrence of DVT and PE in patients who have been previously treated.
• For the prophylaxis of DVT and PE in patients who have undergone hip replacement surgery.

1904 generics available

Dacarbazine

Dacarbazine is indicated in the treatment of metastatic malignant melanoma. In addition, Dacarbazine is also indicated for Hodgkin's disease as a second-line therapy when used in combination with other effective agents.

1904 generics available

Dacomitinib

Dacomitinib is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

1904 generics available

Daclatasvir

Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.

1904 generics available

Daclatasvir + Sofosbuvir

Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-acting   antiviral agent (DAA) against the hepatitis C virus.

1904 generics available

Dalteparin Sodium

Prophylaxis of clotting in extracorporeal circulation in haemodialysis or haemofiltration, Prophylaxis of clotting in extracorporeal circulation in haemodialysis or haemofiltration, Unstable angina, Prophylaxis of venous thromboembolism during surgical procedures, Venous thromboembolism.

1904 generics available

Danazol

Danazol is indicated for the following treatment-

• Endometriosis
• Benign breast disease
• Menorrhagia
• Gynecomastia
• Preoperative thinning of the endometrium before hysteroscopic endometrial ablation.

1904 generics available

Dantrolene Sodium

In Chronic Spasticity: Dantrolene is indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuronal disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patients whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. Dantrolene is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. Occasionally, subtle but meaningful improvement in spasticity may occur with Dantrolene therapy. In such instances, information regarding improvement should be solicited from the patient. Brief withdrawal of Dantrolene for a period of 2 to 4 days will frequently demonstrate exacerbation of the manifestations of spasticity and may serve to confirm a clinical impression.

A decision to continue the administration of Dantrolene on a long-term basis is justified if introduction of the drug into the patient's regimen:

• produces a significant reduction in painful and/or disabling spasticity such as clonus, or
• permits a significant reduction in the intensity and/or degree of nursing care required, or
• rids the patient of any annoying manifestation of spasticity considered important by the patient himself.

In Malignant Hyperthermia: Oral Dantrolene is also indicated preoperatively to prevent or attenuate the development of signs of malignant hyperthermia in known, or strongly suspect, malignant hyperthermia susceptible patients who require anesthesia and/or surgery. Oral Dantrolene should be administered following a malignant hyperthermic crisis to prevent recurrence of the signs of malignant hyperthermia.

1904 generics available

Dapagliflozin Propanediol

Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

1904 generics available

Dapoxetine Hydrochloride

Dapoxetine Hydrochloride is indicated for the treatment of premature ejaculation (PE) in men 18 to 64 years of age, who have one or all of the following:

• Persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes.
• Marked personal distress or interpersonal difficulty as a consequence of PE.
• Poor control over ejaculation.

1904 generics available

Daprodustat

Daprodustat is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.

Daprodustat is not indicated for use:

• As a substitute for red blood cell transfusions in patients who require immediate correction of anemia.
• For treatment of anemia of chronic kidney disease in patients who are not on dialysis.

1904 generics available

Dapsone

Dapsone is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

1904 generics available

Darbepoetin Alfa

Darbepoetin Alfa is indicated for the treatment of anemia due to:

• Chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis.
• The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.

1904 generics available

Darifenacin

Darifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

1904 generics available

Darolutamide

Darolutamide is indicated for the treatment of patients with non-metastatic castration resistant prostate cancer.

1904 generics available

Dasatinib

Dasatinib is indicated for the treatment of adult patients with-

• Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
• Chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including Imatinib.
• Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
• Dasatinib is indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase.
• Newly diagnosed Ph+ ALL in combination with chemotherapy.

1904 generics available

Daunorubicin

Daunorubicin in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

1904 generics available

Decitabine

Decitabine is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.

1904 generics available